Roche to buy U.S. biotech firm InterMune for $8.3 bln | Business Information & News | Westlaw

Roche to buy U.S. biotech firm InterMune for $8.3 bln | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, Roche to buy U.S. biotech firm InterMune for $8.3 bln, Business Information & News
8/25/14 REUTERS 19:26:37
REUTERS
Copyright © 2014 Thomson Reuters
August 25, 2014
Roche to buy U.S. biotech firm InterMune for $8.3 bln
Ben Hirschler
Caroline Copley
LONDON/ZURICH (Reuters) - Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases.
Roche's efforts to...
---- Index References ----
Company: ALEXION PHARMACEUTICALS INC; COVIDIEN; ROCHE HOLDING LTD; INTERMUNE INC; SHIRE PLC; CHUGAI PHARMACEUTICAL CO LTD; GENENTECH INC; ILLUMINA INC; MEDTRONIC INC; ABBVIE INC; BIOMARIN PHARMACEUTICAL INC; CENTERVIEW PARTNERS LLC; GOLDMAN SACHS GROUP INC (THE)
News Subject: (Business Management (1BU42); Corporate Groups & Ownership (1XO09); Mergers & Acquisitions (1ME39); Major Corporations (1MA93); Corporate Events (1CR05))
Industry: (Pharmaceuticals & Biotechnology (1PH13); Oncology & Hematology (1ON95); Internal Medicine (1IN54); Healthcare Practice Specialties (1HE49); Cancer Drugs (1CA21); Biotechnology (1BI78); Drugs (1DR89); Healthcare (1HE06); Pharmaceuticals (1PH33); Biopharmaceuticals (1BI13))
Region: (North America (1NO39); Western Europe (1WE41); Central Europe (1CE50); Americas (1AM92); Switzerland (1SW77); Europe (1EU83))
Language: EN
Other Indexing: (Lucas Jackson; Fabian Wenner; Tim Anderson; Severin Schwan)
Keywords: securities; ma (MCC:OEC); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR); (MCCL:OEC)
Word Count: 852
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.